A
Applied Therapeutics
APLT
5.66000
USD
-0.29
(-4.87%)
مغلق
حجم التداول
50,464
الربح لكل سهم
0
العائد الربحي
0
P/E
-6
حجم السوق
1,044,526,835
الأخبار
العنوان: Applied Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.